Literature DB >> 14506695

High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays.

Jeremy A Squire1, Jianming Pei, Paula Marrano, Ben Beheshti, Jane Bayani, Gloria Lim, Laura Moldovan, Maria Zielenska.   

Abstract

Conventional cytogenetic and comparative genomic hybridization (CGH) studies have shown that osteosarcomas (OSs) are characterized by complex structural and numerical chromosomal alterations and gene amplification. In this study, we used high-resolution CGH to investigate recurrent patterns of genomic imbalance by use of DNA derived from nine OS tumors hybridized to a 19,200-clone cDNA microarray. In six OSs, there was copy number gain or amplification of 6p, with a minimal region of gain centering on segment 6p12.1. In seven OSs, the pattern of amplification affecting chromosome arm 8q showed high-level gains of 8q12-21.3 and 8q22-q23, with amplification of the MYC oncogene at 8q24.2. Seven OSs showed copy number gain or amplification of 17p between the loci bounded by GAS7 and PMI (17p11.2-17p12), and three of these tumors also showed small losses at 17p13, including the region containing TP53. An in silico analysis of the distribution of segmental duplications (duplicons) in this region identified a large number of tracts consisting of paralogous sequences mapping to the 17p region, encompassing the region of deletions and amplifications in OS. Interestingly, within this same region there were clusters of duplicons and several genes that are expressed during bone morphogenesis and in OS. In summary, microarray CGH analysis of the chromosomal imbalances of OS confirm the overall pattern observed by use of metaphase CGH and provides a more precise refinement of the boundaries of genomic gains and losses that characterize this tumor. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14506695     DOI: 10.1002/gcc.10273

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  53 in total

1.  Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma.

Authors:  Jilong Yang; Da Yang; Yan Sun; Baocun Sun; Guowen Wang; Jonathan C Trent; Dejka M Araujo; Kexin Chen; Wei Zhang
Journal:  Cancer       Date:  2011-04-14       Impact factor: 6.860

Review 2.  Chromosome 6p amplification and cancer progression.

Authors:  Gda C Santos; M Zielenska; M Prasad; J A Squire
Journal:  J Clin Pathol       Date:  2006-06-21       Impact factor: 3.411

Review 3.  From microscopes to microarrays: dissecting recurrent chromosomal rearrangements.

Authors:  Beverly S Emanuel; Sulagna C Saitta
Journal:  Nat Rev Genet       Date:  2007-11       Impact factor: 53.242

Review 4.  Methods and strategies for analyzing copy number variation using DNA microarrays.

Authors:  Nigel P Carter
Journal:  Nat Genet       Date:  2007-07       Impact factor: 38.330

5.  The breakage-fusion-bridge (BFB) cycle as a mechanism for generating genetic heterogeneity in osteosarcoma.

Authors:  Shamini Selvarajah; Maisa Yoshimoto; Paul C Park; Georges Maire; Jana Paderova; Jane Bayani; Gloria Lim; Khaldoun Al-Romaih; Jeremy A Squire; Maria Zielenska
Journal:  Chromosoma       Date:  2006-08-09       Impact factor: 4.316

6.  Quantifying the mechanisms for segmental duplications in mammalian genomes by statistical analysis and modeling.

Authors:  Yi Zhou; Bud Mishra
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-01       Impact factor: 11.205

7.  MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema.

Authors:  Johanna Manner; Bernhard Radlwimmer; Peter Hohenberger; Katharina Mössinger; Stefan Küffer; Christian Sauer; Djeda Belharazem; Andreas Zettl; Jean-Michel Coindre; Christian Hallermann; Jörg Thomas Hartmann; Detlef Katenkamp; Kathrin Katenkamp; Patrick Schöffski; Raf Sciot; Agnieszka Wozniak; Peter Lichter; Alexander Marx; Philipp Ströbel
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

8.  Standardized genetic alteration score and predicted score for predicting recurrence status of gastric cancer.

Authors:  Mijung Kim; Hyun Cheol Chung
Journal:  J Cancer Res Clin Oncol       Date:  2009-05-16       Impact factor: 4.553

9.  Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy.

Authors:  Bekim Sadikovic; Paul Thorner; Susan Chilton-Macneill; Jeff W Martin; Nilva K Cervigne; Jeremy Squire; Maria Zielenska
Journal:  BMC Cancer       Date:  2010-05-13       Impact factor: 4.430

10.  Organization of the amplified type I interferon gene cluster and associated chromosome regions in the interphase nucleus of human osteosarcoma cells.

Authors:  Michael J Zeitz; Narasimharao V Marella; Kishore S Malyavantham; Sandra Goetze; Juergen Bode; Ivan Raska; Ronald Berezney
Journal:  Chromosome Res       Date:  2009-03-13       Impact factor: 5.239

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.